Vancomycin sensitivity of methicillin resistant Staphylococcus aureus (MRSA) isolates collected from clinical specimens of Tabriz Imam Reza and Sina hospitals by E-test method, agar screening plate and PCR

Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 121

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJMM-10-1_008

تاریخ نمایه سازی: 16 مرداد 1402

Abstract:

Background and Aim: Vancomycin is one of the last drugs used by human for treatment of infections caused by Methicillin resistant Staphylococcus aureus (MRSA) isolates. Since Staphylococcus aureus with heterogeneous, intermediate and complete resistance to vancomycin are in relation to high mortality rate and are increasing in the world, so investigating the incidence of these isolates is necessary. Materials and Methods: By using several phenotypic tests such as Gram stain, catalase, coagulase, DNase and mannitol fermentations and by screening resistance to methicillin, ۱۰۰ MRSA isolates were identified. For identifying resistance to vancomycin, phenotypic tests with the disc diffusion method, determining MIC by E-test method and screening test in BHIA (Brain Heart Infusion Agar) containing vancomycin and molecular PCR test were carried out in order to identify femB, mecA and vanA genes. Results: Resistance to methicillin was ۵۹%. Ranges of vancomycin MICs were between ۰.۷۵ µg/ml to ۴ µg/ml. By E-test method ۹۲% of isolates were sensitive and ۸% showed heterogeneous resistance to vancomycin. However, screening tests in BHIA, containing ۳ μg/ml and ۴ μg/ml vancomycin, detected ۱۸% heterogeneous resistance and ۴% intermediate resistance to vancomycin, respectively. In screening tests using BHIA, with ۶ μg/ml vancomycin no isolate was able to grow. Although all of the isolates contained femB and mecA genes, but none of them contained vanA gene. Conclusion: E-test alone was not able to identify all S.aureus isolates of heterogeneous resistance and intermediate resistance to vancomycin. As a result, the screening tests also should be used along with MIC tests.

Keywords:

Methicillin- resistant Staphylococcus aureus , Vancomycin , E-test , Screening test , PCR , استافیلوکوکوس اورئوس مقاوم به متی سیلین , وانکومایسین , E-test , آزمون غربالی , PCR

Authors

Peyman Bohlouli

International Branch of Aras Tabriz University of Medical Sciences, Tabriz, Iran

Mohammad Reza Nahaei

School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Safar Farajnia

Tabriz University of Medical Sciences, Tabriz, Iran

Mojtaba Varshochi

Tabriz University of Medical Sciences, Tabriz, Iran

Morteza Ghojazadeh

School of Medicine,Tabriz University of Medical Sciences,Tabriz,Iran

Mohammad Akbari Dibavar

School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Firoozeh Safaeeyan

School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Johnston Bl, Bryce E. hospital infection control strategies for vancomycin-resistant ...
  • Azimian A, Havaei SA, Fazeli H. Genetic characterization of a ...
  • Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. ...
  • Tiwari KB. Vancomycin resistance in Staphylococcus aureus may occur faster ...
  • Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, ...
  • Horne KC, Howden BP, Grabsch EA, Graham M, Ward PB, ...
  • Jones RN. Microbiological features of vancomycin in the ۲۱st century: ...
  • Performance standards for antimicrobial susceptibility testing, ۲۱th ed. CLSI document ...
  • CDC-VISA/VRSA-vancomycin-Intermediate/Resistant Staphylococcus aureus -Fact Sheet. (۱۹۹۸). Morb Mortal Wkly Rep. ...
  • Khan F, Shukla I, Rivzi M. The role of non-β-lactam ...
  • Moise PA, Smyth DS, Robinson DA, Fawal NE, McCalla C, ...
  • McDougal LK, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant ...
  • Burnham CA, Weber CJ, Michael WM. Novel Screening Agar for ...
  • Riederer K, Shemes S, Chase P, Musta A, Mar A, ...
  • Zhang K, McClure JA, Elsayed S, Louie T, Conly JM. ...
  • Liu D. Molecular Detection of Human Bacterial Pathogens. Taylor and ...
  • Naseer BS, Jayaraj YM. Identification of multiresistant Staphylococcus aureus in ...
  • Kalia A, Rattan A, Chopra P. (۱۹۹۹). A method for ...
  • Ghaznavi-Rad E, Nor Shamsudin M, Sekawi Z, van Belkum A, ...
  • Horne KC, Howden BP, Grabsch EA, Graham M, Ward PB, ...
  • Jones RN. Microbiological features of vancomycin in the ۲۱st century: ...
  • Ahmadishoar SH, Nahaei MR, Amirmozafari N. Sensitivity of Staphylococcus aureus ...
  • Arakawa Y, Ike Y, Nagasawa M. Where has vancomycin-heterogeneously resistant ...
  • Sancak B, Ercis S, Menemenlioglu D, Colakoglu S, Hascelik G. ...
  • Moradi N, Javadpour S, Karmostaji A. Reduced sensitivity of Staphylococcus ...
  • Tiwari KB. Vancomycin resistance in Staphylococcus aureus may occur faster ...
  • Mohraz M, Joneidi N, Rasouli Nejad M, Boroumand MA, Aligholi ...
  • Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant ...
  • Saffari M, Jokar M, Shajary GR, Piroozmand A, Mousavi GA. ...
  • Haghgoo SM, Moaddab SR, Rafi A. Study of antibiotic resistance ...
  • نمایش کامل مراجع